{{Drugbox
| IUPAC_name = 2-(naphthalene-1-carbonyl)-1-pentyl-1''H''-1,3-benzodiazole
| image = BIM-018_structure.png

<!--Clinical data-->
| tradename =  
| pregnancy_AU = 
| pregnancy_US = 
| pregnancy_category =  
| legal_AU = 
| legal_CA = Schedule II
| legal_UK = 
| legal_US = 
| legal_status = 
| routes_of_administration =

<!--Pharmacokinetic data-->
| bioavailability =  
| protein_bound =  
| metabolism =  
| elimination_half-life =  
| excretion =

<!--Identifiers-->
| CAS_number_Ref = 
| CAS_number = 
| ATC_prefix =  
| ATC_suffix =  
| PubChem =  
| ChemSpiderID      = 29763750
| smiles            = CCCCCn1c2ccccc2nc1C(=O)c1cccc2c1cccc2
| StdInChI          = 1S/C23H22N2O/c1-2-3-8-16-25-21-15-7-6-14-20(21)24-23(25)22(26)19-13-9-11-17-10-4-5-12-18(17)19/h4-7,9-15H,2-3,8,16H2,1H3
| StdInChIKey       = ZJWSSWFQIOEVCU-UHFFFAOYSA-N

<!--Chemical data-->
| C=23 | H=22 | N=2 | O=1
| molecular_weight = 342.4 g/mol
}}

'''BIM-018''' is a synthetic [[cannabinoid]] that is the [[benzimidazole]] [[structural analog|analog]] of [[JWH-018]]. It is presumed to be a potent [[agonist]] of the [[CB2 receptor|CB<sub>2</sub> receptor]] and has been sold online as a [[designer drug]].<ref>{{cite web | url=https://www.caymanchem.com/app/template/Product.vm/catalog/15074 | title=BIM-018 | publisher=Cayman Chemical | accessdate=24 July 2015}}</ref>

Related benzimidazole derivatives have been reported to be highly selective [[agonist]]s for the [[Cannabinoid receptor type 2|CB<sub>2</sub> receptor]].<ref>{{cite journal | url=http://www.sciencedirect.com/science/article/pii/S0960894X08005817 | title=Novel benzimidazole derivatives as selective CB<sub>2</sub> agonists |author1=Daniel Pagé |author2=Elise Balaux |author3=Luc Boisvert |author4=Ziping Liu |author5=Claire Milburn |author6=Maxime Tremblay |author7=Zhongyong Wei |author8=Simon Woo |author9=Xuehong Luo |author10=Yun-Xing Cheng |author11=Hua Yang |author12=Sanjay Srivastava |author13=Fei Zhou |author14=William Brown |author15=Miroslaw Tomaszewski |author16=Christopher Walpole |author17=Leila Hodzic |author18=Stéphane St-Onge |author19=Claude Godbout |author20=Dominic Salois |author21=Keymal Payza | journal=Bioorganic & Medicinal Chemistry Letters |date=July 2008  | volume=18 | issue=13 | pages=3695–3700 | doi=10.1016/j.bmcl.2008.05.073 | pmid=18522867}}</ref>

==See also==
{{div col|colwidth=30em}}
* [[AM-2201]]
* [[FUBIMINA]]
* [[List of AM cannabinoids]]
* [[List of JWH cannabinoids]]
* [[THJ-018]]
* [[THJ-2201]]
{{Div col end}}

==References==
{{reflist}}

{{Cannabinoids}}
{{Cannabinoidergics}}

[[Category:Benzimidazoles]]
[[Category:Cannabinoids]]
[[Category:Designer drugs]]


{{cannabinoid-stub}}